The Evaluation And Promational Strategy Of Innovative Capacity In A Company From Guangdong Province

The pharmaceutical industry is a combination of modern technology and meansof production of high-tech group, related to the national health, social stability andeconomic development. With economic globalization, international competitioncontinue to strengthen, the pharmaceutical industry, the competition has becomefiercer than ever before. Pharmaceutical multinationals in order to enhance itsinternational competitiveness, through large-scale capital investment, theestablishment of the global production and sales network, expand market share,competitors of China’s pharmaceutical industry has become more powerful. In thiscontext, innovation was the level of China’s pharmaceutical businesses’ access to thecore competitiveness of key. Therefore, to carry out the evaluation of the ability ofenterprises to innovate, identify and judge the level of enterprise innovation ability,and effectively enhance the innovative capability of enterprises is an important wayfor sustainable development of enterprises.According to the survey constitusion from A Company,this paper based oninnovation management theory, using a combination of theoretical analysis andempirical analysis, case studies and other methods to evaluate the innovationcapability of enterprises A and associated lifting strategy. This article provides anoverview of the theory of enterprise innovation ability, particularly focused onenterprise innovation ability evaluation theory; build A corporate innovationcapability evaluation index, and brief introduction to the basic idea of the principalcomponent analysis evaluation model and steps; once again, based on building a goodevaluation and model to conduct a detailed and comprehensive evaluation ofinnovation ability evaluation of Company A, according to the evaluation resultsobtained, analyzed enterprise innovation capabilities are limiting factors;, GuangdongProvince a corporate innovation capability strategy.In this paper, A Company of Guangdong Province as an object, ruthor researchsystematilly enterprise innovation ability of the pharmaceutical industry and relatedupgrading strategy, its main contribution is: enrich innovation management theory;expand the field of enterprise innovation ability, but also for the pharmaceuticalindustry other enterprises in the future innovation capacity study provides animportant reference.